Fulgent Genetics has been making significant strides under its current management, which has led to a more optimistic view among investors.
The company's strategic decisions are aimed at fostering growth and stability, which are crucial in the competitive landscape of genetics.
Recent developments suggest that the management's approach is resonating well with stakeholders, reinforcing a bullish sentiment in the market.